Literature DB >> 22859662

Synthetic cannabinoid and marijuana exposures reported to poison centers.

M B Forrester1, K Kleinschmidt, E Schwarz, A Young.   

Abstract

Synthetic cannabinoids have recently gained popularity as a recreational drug because they are believed to result in a marijuana-like high. This investigation compared synthetic cannabinoids and marijuana exposures reported to a large statewide poison center system. Synthetic cannabinoid and marijuana exposures reported to Texas poison centers during 2010 were identified. The distribution of exposures to the two agents with respect to various demographic and clinical factors were compared by calculating the rate ratio (RR) of the synthetic cannabinoid and marijuana percentages for each subgroup and 95% confidence interval (CI). The proportion of synthetic cannabinoid and marijuana exposures, respectively, were 87.3% and 46.5% via inhalation (RR 1.88, 95% CI 1.38-2.61), 74.9% and 65.7% in male (RR 1.14, 95% CI 0.87-1.51), 40.2% and 56.6% age ≤ 19 years (RR 0.71, 95% CI 0.52-0.98), 79.2% and 58.6% occurring at a residence (RR 1.35, 95% CI 1.02-1.82), 8.4% and 16.2% managed on-site (RR 0.52. 95% CI 0.28-1.00), and 59.3% and 41.4% with serious medical outcomes (RR 1.43, 95% CI 1.03-2.05). Compared to marijuana, synthetic cannabinoid exposures were more likely to be used through inhalation, to involve adults, to be used at a residence, and to result in serious outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859662     DOI: 10.1177/0960327111421945

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  30 in total

1.  Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Authors:  Jenny L Wiley; Julie A Marusich; Timothy W Lefever; Megan Grabenauer; Katherine N Moore; Brian F Thomas
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

2.  CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.

Authors:  Niels Bjerre Holm; Line Marie Nielsen; Kristian Linnet
Journal:  AAPS J       Date:  2015-05-23       Impact factor: 4.009

3.  The Importance of Recognizing Cannabinoid Hyperemesis Syndrome from Synthetic Marijuana Use.

Authors:  Xibei Liu; Angela Villamagna; Ji Yoo
Journal:  J Med Toxicol       Date:  2017-03-28

4.  K2 and Spice use among a cohort of college students in southeast region of the USA.

Authors:  Kathleen L Egan; Cynthia K Suerken; Beth A Reboussin; John Spangler; Kimberly G Wagoner; Erin L Sutfin; Beata Debinski; Mark Wolfson
Journal:  Am J Drug Alcohol Abuse       Date:  2015-06-01       Impact factor: 3.829

Review 5.  Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.

Authors:  Vikas Khullar; Ankur Jain; Maryam Sattari
Journal:  J Gen Intern Med       Date:  2014-02-20       Impact factor: 5.128

6.  A 15-year-old boy with acute onset abdominal pain and hypertension.

Authors:  Rosheen Mary Grady; Vladimir Belostotsky; Kristen M Hallett; Christina N Grant
Journal:  Paediatr Child Health       Date:  2017-06-14       Impact factor: 2.253

7.  In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).

Authors:  Xingxing Diao; Jeremy Carlier; Mingshe Zhu; Shaokun Pang; Robert Kronstrand; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Forensic Toxicol       Date:  2016-07-06       Impact factor: 4.096

8.  High times, low sats: diffuse pulmonary infiltrates associated with chronic synthetic cannabinoid use.

Authors:  Sameir Alhadi; Anupama Tiwari; Rais Vohra; Roy Gerona; Janak Acharya; Kathryn Bilello
Journal:  J Med Toxicol       Date:  2013-06

9.  Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors.

Authors:  S Grassin-Delyle; E Naline; A Buenestado; C Faisy; J-C Alvarez; H Salvator; C Abrial; C Advenier; L Zemoura; P Devillier
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates.

Authors:  Erin E Bonar; Lisham Ashrafioun; Mark A Ilgen
Journal:  Drug Alcohol Depend       Date:  2014-07-17       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.